Signal pathways and precision therapy of small-cell lung cancer

M Yuan, Y Zhao, HT Arkenau, T Lao, L Chu… - Signal transduction and …, 2022 - nature.com
Small-cell lung cancer (SCLC) encounters up 15% of all lung cancers, and is characterized
by a high rate of proliferation, a tendency for early metastasis and generally poor prognosis …

Advances in MicroRNA therapeutics: From preclinical to clinical studies

S Brillante, M Volpe, A Indrieri - Human Gene Therapy, 2024 - liebertpub.com
MicroRNAs (miRNAs) are crucial regulators of gene expression involved in various
pathophysiological processes. Their ability to modulate multiple pathways simultaneously …

[HTML][HTML] A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice

A Bahreyni, H Liu, Y Mohamud, YC Xue, J Zhang… - Cancer Letters, 2022 - Elsevier
Abstract Coxsackievirus B3 (CVB3) displays great oncolytic activity against various cancer
cells. Previously, we demonstrated that adding targeting sequences (TS) of miR-145/143 …

Coxsackievirus B3—its potential as an oncolytic virus

A Geisler, A Hazini, L Heimann, J Kurreck, H Fechner - Viruses, 2021 - mdpi.com
Oncolytic virotherapy represents one of the most advanced strategies to treat otherwise
untreatable types of cancer. Despite encouraging developments in recent years, the limited …

[HTML][HTML] Lung cancer and oncolytic virotherapy——enemy's enemy

Z Li, Z Feiyue, L Gaofeng, L Haifeng - Translational Oncology, 2023 - Elsevier
Lung cancer is one of the malignant tumors that seriously threaten human health worldwide,
while the covid-19 virus has become people's nightmare after the coronavirus pandemic …

A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy

A Bahreyni, H Liu, Y Mohamud, YC Xue, YM Fan… - BMC medicine, 2023 - Springer
Background Immunotherapy has emerged as an efficient therapeutic approach for cancer
management. However, stimulation of host immune system against cancer cells often fails to …

[HTML][HTML] MiRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses

M Toropko, S Chuvpilo, A Karabelsky - Pharmaceutics, 2024 - mdpi.com
MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by
inhibiting the translation of target transcripts. The expression profiles of miRNAs vary in …

Development of group B coxsackievirus as an oncolytic virus: opportunities and challenges

H Liu, H Luo - Viruses, 2021 - mdpi.com
Oncolytic viruses have emerged as a promising strategy for cancer therapy due to their dual
ability to selectively infect and lyse tumor cells and to induce systemic anti-tumor immunity …

Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies

N Kiaheyrati, A Babaei, R Ranji, E Bahadoran, S Taheri… - Life Sciences, 2024 - Elsevier
Cancer continues to be one of the leading causes of mortality worldwide despite significant
advancements in cancer treatment. Many difficulties have arisen as a result of the …

Identified GNGT1 and NMU as combined diagnosis biomarker of non‐small‐cell lung cancer utilizing bioinformatics and logistic regression

JJ Zhang, J Hong, YS Ma, Y Shi, DD Zhang… - Disease …, 2021 - Wiley Online Library
Non‐small‐cell lung cancer (NSCLC) is one of the most devastating diseases worldwide.
The study is aimed at identifying reliable prognostic biomarkers and to improve …